Encyclopedia of AIDS

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Hope, Thomas J. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Richman, Douglas (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Stevenson, Mario (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: New York, NY : Springer New York : Imprint: Springer, 2018.
• Έκδοση: 1st ed. 2018.
• Θέματα: Infectious diseases.; Immunology.; Virology.; Infectious Diseases.

 For the first time, the world's experts in HIV-AIDS have come together to publish the Encyclopedia of AIDS. The work features over 4,000 A-Z entries including medical, cultural, social, and pharmacological essays. The Pathology entries cover the various types of HIV-related illnesses, including those that are and are not AIDS-defining. Many of the conditions that are AIDS-defining illnesses have their own entries or are cross-referenced to a generic entry in which several related conditions are discussed (such as enteric diseases and fungal infections). Typically, the treatment of any given form of pathology is briefly discussed in the entry that covers that illness. The reference is a must-read for Infectious Disease specialists, Immunologists, Public Health researchers, Virologists, Microbiologists, Pharmacologists, and Physicians. 

 Abstinence, Be Faithful, Condoms (ABC), Prevention of HIV -- Acetylation -- Actin -- AIDS-related -- Primary Central Nervous System Lymphoma -- Anal Cancer -- Anatomic Compartments as a Barrier to HIV Cure -- Antiretroviral Drug Penetration into Lymphoid Tissue -- Antiretroviral Drug Penetration into the CNS Compartment -- Antiretroviral Medications, Adult Care and Treatment -- Antiretroviral therapy (ART), Prevention of HIV -- Anti-Retroviral Therapy and Drug Resistance in HIV-2 Infection -- Antiretroviral Therapy for HIV-Infected Infants, Children, and Adolescents in Resource-Rich Settings -- Antiretroviral Therapy: When to Start -- Antiretroviral Treatment in Resource-Limited Settings -- APOBEC3F/G and Vif: Action and Counteractions -- Apoptosis Dysregulation during HIV Disease.-Arp2/3 -- Attachment/Binding -- Autophagy and HIV Infection -- Bacterial Respiratory and Invasive Pneumococcal Infections and HIV -- BAF (BANF1) -- Behavioral Aspects of HIV Mother-to-Child Transmission -- Behavioral Aspects of HIV Treatment as Prevention -- Behavioral Interventions for Adherence -- Behavioral Science highlights of evidence and research -- Blood and blood product donors and recipients in China, Epidemiology of HIV/AIDS -- Budding -- Burkitt and Burkitt-like Lymphoma -- Cardiovascular Complications -- cART and Supportive Care for HIV-Associated Malignancies -- Case Management for Linkage -- Cell Intrinsic Immunity -- Cellular and Soluble Immune Activation Markers in HIV-Infected Subjects -- Cellular Cofactors for HIV-1 Transcription -- Cellular Cofactors of HIV as Drug Targets -- Central Memory CD4 T cells -- Cervical Cancer and HIV -- Chagas Disease and HIV -- Children, Care and Treatment -- Children, Epidemiology of HIV/AIDS -- Chronic Immune Activation in HIV -- Circumcision and AIDS -- Clinical Ethics in HIV/AIDS Prevention, Care, and Research -- Cofilin, Trafficking -- Collagen Deposition and Fibrosis in the Lymphatic Tissues of HIV-1 Infected Individuals -- Combination Approaches to HIV Prevention -- Community Viral Load -- Co-morbidity: Opiods -- Comorbidity: Progressive Multifocal Leukoencephalopathy -- Conjunctival Carcinoma -- Counteraction of SAMHD1 by Vpx -- Chromosome Region Maintenance 1 (CRM1) -- Cryptococcosis and HIV -- Cryptosporidiosis -- Epidemic Kaposi Sarcoma, Pathogenesis and Presentation of -- CXCR4, Coreceptors -- Cyclophilin A and HIV-1 Replication -- Cystoisosporiasis -- Cytomegalovirus Infection and HIV -- DDX3, Cofactors, and RNA Export -- Delayed Sexual Debut -- Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein, Implications for Preventing Transmission -- Differential Diagnosis of HIV-Associated Neurocognitive Disorders -- Diffuse Large B-Cell Lymphoma -- Eastern Europe and Central Asia, specific characteristics of HIV/AIDS epidemic -- Elderly: Epidemiology of HIV/AIDS -- Entry Inhibitors -- Epidemiology of AIDS-Defining Malignancies -- Epidemiology of HIV-2 Infection in West Africa -- Epidemiology of Non-AIDS-Defining Malignancies -- Epstein Barr Virus (EBV) -- Faith Based Interventions -- Family Interventions -- Female Condoms -- Female, Male and Transgender Sex Workers, Epidemiology of HIV/AIDS -- Fusion -- Gamma delta T cells -- Global NeuroAIDS -- HAND Adjunctive Therapies: Reversing Neuronal Injury -- Harm Reduction for Injection Drug Users -- Health care workers, Epidemiology of HIV/AIDS -- Health care workers, Shortage and task shifting of -- Hepatitis B Virus infection and HIV -- Hepatitis C Virus Infection and HIV -- Hepatocellular Carcinoma in HIV-Positive Patients -- History of the AIDS epidemic -- HIV "auxiliary" proteins, essential role of -- HIV & SIV, CD4 T cell responses to -- HIV and Opportunistic Infections, an Overview -- HIV and Sexual Violence -- HIV and SIV, B-Cell Responses to -- HIV and SIV, CD8 T Cell Responses to -- HIV Antigen Processing and Presentation -- HIV Associated Immune Exhaustion -- HIV Cancers in Resource-Limited Regions -- HIV Compartments and Viral Rebound During Treatment Interruption -- HIV Coreceptor Tropism in Different Reservoirs -- HIV Counseling and Testing, Prevention of HIV -- HIV Funding agencies and major programs -- HIV Infection, Immune-based Interventions for -- HIV Life Cycle: Overview -- HIV Neurocognitive Diagnosis, Natural History and Treatment -- HIV Prevention and African Americans -- HIV Prevention and Asians and Pacific Islanders -- HIV Prevention and Hispanics -- HIV Prevention and Labor Migration -- HIV Prevention and Women -- HIV Prevention Efforts Within Substance Use Disorder Treatment Settings -- HIV Prevention for MSM -- HIV Prevention for Serodiscordant Couples -- HIV Prevention for Stimulant Using Men Who have Sex with Men -- HIV Prevention in Persons 50 and Older -- HIV Prevention in the Correctional System -- HIV Prevention in Transgender Persons -- HIV Prevention in Youth -- HIV Reservoirs in Lymph Nodes and Spleen -- HIV Reservoirs in the Central Nervous System -- HIV Reservoirs Within the Lungs -- HIV Testing and Counseling -- HIV Transmission in Female Commercial Sex Workers and Host Protective Factors -- HIV-1 Assembly Cofactors -- HIV-1 Maturation -- HIV-1 Mutational Escape from Host Immunity -- HIV-1 Pathogenesis in the Gut -- HIV-1 Pre-Exposure Prophylaxis -- HIV-1 Prevention Using Live-attenuated Vaccines -- HIV-1 Rev Expression and Functions -- HIV-1 Transmission Blocking Microbicides -- HIV-1 Transmission; Influence of Bodily Secretions -- HIV-1 Virion Structure -- HIV-2 Diagnosis and Viral Load Measurements -- HIV-2 Envelope: Structure, Diversity and Evolution -- HIV-2 Infection in Europe, Epidemiology of -- HIV-2 Infection: The Role of Immune Activation in Pathogenesis -- HIV-2 Neurological Manifestations -- HIV-2 Transmission -- HIV-2: Lessons from the Dakar Cohort -- HIV-Associated Cancers -- Hodgkin Lymphoma in Patients with HIV Infection -- Host Genetics and Genomics -- Housing as HIV Prevention -- Human Papillomavirus (HPV) -- Identification and Validation of HIV Cofactors -- Identifying Opportunities to Block HIV-1 Transmission in the Female Genital Tract -- Immune Activation and HIV Transmission -- Immunogenetics of HIV-2 Infection -- Immunological Responses to Antiretroviral Therapy -- Immunology of Latent HIV Infection -- Immunopathogenesis of HIV Co-infections -- Inflammasome and HIV -- Inflammatory Cytokines -- Inhibition of HIV-1 Spread: Cell-Free Versus Cell-Cell -- Initial Antiretroviral Regimens -- Integrase Inhibitors -- Integration -- Integrin Alpha4beta7 -- Interactions Between HIV-2 and Host Restriction Factors -- Kaposi's Sarcoma-associated Herpesvirus (KSHV) or Human Herpesvirus 8 (HHV-8) -- KIR Locus Variation -- Latin America and the Caribbean, specific characteristics of HIV/AIDS epidemic -- Leishmaniasis and HIV -- Long-Acting Nanoformulated Antiretroviral Therapy -- Long-Term Nonprogressors and Elite Controllers -- Lung Cancer -- M.